Sarcoidosis: Research into the Cause of Multi-organ Disease and Clinical Strategies for Therapy (R01)
The summary for the Sarcoidosis: Research into the Cause of Multi-organ Disease and Clinical Strategies for Therapy (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Sarcoidosis: Research into the Cause of Multi-organ Disease and Clinical Strategies for Therapy (R01): The primary objective of this program announcement is to stimulate research on the etiology and management of sarcoidosis, a human disorder of granulomatous inflammation. We encourage research that seeks to identify not only the cause of sarcoidosis, but seeks related predisposing factors, such as genomic, proteomic, metabolomic, lipidomic or glycomic factors related to the etiology of sarcoidosis. Investigations might include how sarcoidosis perturbs the innate and acquired immunity systems; affects multi-organs within the human body; and impacts biobehavioral and psychosocial factors of the individual, family, and community. The goal is to delineate possible causes and phenotypic host characteristics in susceptible or at risk people so that preventive strategies can be developed, early diagnosis improved, and better antidotes or therapy devised to lessen initial disease immunopathology. Interventions that are cost effective and reduce the individual,! family, and community burden of the disease are also encouraged. Also, there is interest for approaches to risk reduction, psychological coping, and management of complications or side effects of treatment.
Federal Grant Title: | Sarcoidosis: Research into the Cause of Multi-organ Disease and Clinical Strategies for Therapy (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-06-123 |
Type of Funding: | Grant |
CFDA Numbers: | 93.36193.838 |
CFDA Descriptions: | Nursing Research 93.838 Lung Diseases Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Posted Date: | Jan 20, 2006 |
Creation Date: | Dec 12, 2006 |
Archive Date: | Feb 03, 2007 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | 93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research |
- Applicants Eligible for this Grant
- Special district governments County governments For profit organizations other than small businesses Public and State controlled institutions of higher education State governments Independent school districts Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities City or township governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments)
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster